Xention Ltd.
🇬🇧United Kingdom
Clinical Trials
10
Active:0
Completed:10
Trial Phases
2 Phases
Phase 1:6
Phase 2:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Phase 1
6 (60.0%)Phase 2
4 (40.0%)Bioequivalence Study of Capsule and Tablet Formulations of TA-8995
- First Posted Date
- 2015-08-14
- Last Posted Date
- 2016-01-29
- Lead Sponsor
- Xention Ltd
- Target Recruit Count
- 26
- Registration Number
- NCT02523391
- Locations
- 🇬🇧
Covance Clinical Research Unit Ltd, Leeds, United Kingdom
ADME Study in Healthy Male Subjects With TA-8995
- First Posted Date
- 2015-04-03
- Last Posted Date
- 2016-10-03
- Lead Sponsor
- Xention Ltd
- Target Recruit Count
- 6
- Registration Number
- NCT02408055
- Locations
- 🇬🇧
Covance Clinical Research Unit Ltd, Leeds, United Kingdom
Fed-Fasted, Single and Multiple Ascending Dose Trial of XEN-D0103
Phase 1
Completed
- Conditions
- Atrial Fibrillation
- Interventions
- Drug: PlaceboDrug: 10mg XEN-D0103Drug: 200mg XEN-D0103Drug: 30mg XEN-D0103Drug: 60mg XEN-D0103Drug: 120mg XEN-D0103Drug: 150mg XEN-D0103
- First Posted Date
- 2015-03-17
- Last Posted Date
- 2015-03-18
- Lead Sponsor
- Xention Ltd
- Target Recruit Count
- 87
- Registration Number
- NCT02390258
- Locations
- 🇬🇧
ICON Development Solutions, Manchester, United Kingdom
A Study on the Effects of TA-8995 on Lp(a) in Subjects With Elevated Lp(a)
- First Posted Date
- 2014-09-16
- Last Posted Date
- 2015-02-16
- Lead Sponsor
- Xention Ltd
- Target Recruit Count
- 42
- Registration Number
- NCT02241772
- Locations
- 🇩🇰
Herlev Hospital, Herlev, Denmark
Study of the Electrocardiographic Effects of TA-8995
- First Posted Date
- 2014-09-16
- Last Posted Date
- 2015-02-16
- Lead Sponsor
- Xention Ltd
- Target Recruit Count
- 136
- Registration Number
- NCT02241759
- Locations
- 🇬🇧
Covance Clinical Research Unit Ltd, Leeds, United Kingdom
- Prev
- 1
- 2
- Next
News
No news found